XML 78 R66.htm IDEA: XBRL DOCUMENT
v3.24.3

Derivative Liabilities (Details) - Schedule of Derivative Liability Warrants Outstanding - Derivative Liability Warrants [Member] | 9 Months Ended
--- | ---
Sep. 30, 2024 $ / shares shares
Schedule of Derivative Liability Warrants Outstanding [Line Items] |  |
Outstanding | shares | 306,828 |
Weighted average exercise price | $ / shares | $ 2.5 |
April 27, 2027 [Member] |  |
Schedule of Derivative Liability Warrants Outstanding [Line Items] |  |
Outstanding | shares | 75,840 |
Expiry date | Apr. 27, 2027 | [1]
Weighted average exercise price | $ / shares | $ 2.01 |
April 27, 2027 [Member] |  |
Schedule of Derivative Liability Warrants Outstanding [Line Items] |  |
Outstanding | shares | 63,037 |
Expiry date | Apr. 27, 2027 | [1]
Weighted average exercise price | $ / shares | $ 2.01 |
April 27, 2027 [Member] |  |
Schedule of Derivative Liability Warrants Outstanding [Line Items] |  |
Outstanding | shares | 80,388 |
Expiry date | Apr. 27, 2027 | [1]
Weighted average exercise price | $ / shares | $ 2.01 |
April 27, 2027 [Member] |  |
Schedule of Derivative Liability Warrants Outstanding [Line Items] |  |
Outstanding | shares | 12,563 |
Expiry date | Apr. 27, 2027 | [1]
Weighted average exercise price | $ / shares | $ 2.01 |
November 21, 2028 [Member] |  |
Schedule of Derivative Liability Warrants Outstanding [Line Items] |  |
Outstanding | shares | 75,000 |
Expiry date | Nov. 21, 2028 | [1]
Weighted average exercise price | $ / shares | $ 4 |
[1] | On April 28, 2023, the Company amended the warrant agreements for the 231,828 derivative liability warrants outstanding. The amendment removed the clause to automatically convert warrants to shares on IPO date and all warrants were given an expiry date of April 27, 2027. This led to an increase in the expected life input in the Black-Scholes model as of December 31, 2023, compared to December 31, 2022, when the Company used the expected IPO date to calculate the expected life of the warrants.

X
- Definition Date the equity-based award expires, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=elab_DerivativeLiabilityWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=elab_AprilTwentySevenTwoThousandTwentySevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=elab_AprilTwentySevenTwoThousandTwentySevenOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=elab_AprilTwentySevenTwoThousandTwentySevenTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=elab_AprilTwentySevenTwoThousandTwentySevenThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=elab_NovemberTwentyOneTwoThousandTwentyEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |